The latest market price and purchasing reference information of Imatinib

Imatinib (Imatinib) is an oral targeted drug mainly used to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumor (GIST) and other diseases. As a first-generation tyrosine kinase inhibitor, imatinib can specifically inhibit abnormally activated signaling pathways such as BCR-ABL, c-KIT and PDGFR, thereby effectively controlling tumor cell proliferation and disease progression.

In the domestic market, imatinib has been launched and is included in medical insurance. The commonly used specification is 100mg*60 tablets, and the price per box is about six to seven hundred yuan. The specific medical insurance reimbursement amount and actual payment price will vary depending on region and hospital policies. Patients should consult the local hospital pharmacy before purchasing to ensure that the cost of medication is controllable. After being included in medical insurance, the patient's financial burden is significantly reduced, and it also makes long-term medication possible.

In foreign markets, the price of generic imatinib is relatively lower. For example, each box of 100mg*120 generic drugs produced in India costs about three to four hundred yuan, and the drug ingredients are basically the same as domestic generic drugs. This provides a more economical option for patients who require long-term treatment, especially when cost pressure is high, and can effectively reduce treatment costs while ensuring efficacy.

Generally speaking, imatinib has original drugs and generic drugs available at home and abroad. When purchasing, patients should give priority to obtaining drugs through regular hospital pharmacies or legal channels to ensure drug quality and medication safety. At the same time, rational selection of drug specifications and versions based on the doctor's treatment plan, medical insurance policy, and own economic conditions can reduce medication costs and achieve long-term safe medication while ensuring efficacy.

Reference materials:https://www.drugs.com/